Business Context and Reporting Period
This Form 8-K Current Report was filed by SilverSun Technologies, Inc. (noted as QXO, Inc. in metadata) on March 29, 2017, covering events occurring on March 27, 2017. The filing details the appointment of a new director, the execution of a director agreement, and the restructuring of board committees.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The only financial figures disclosed relate to specific compensatory arrangements:
- Director Cash Compensation: $1,000 per month for the term of service.
- Director Equity Compensation: A warrant to purchase up to 5,000 shares of common stock.
- Warrant Terms: Exercise price of $4.01 per share; 5-year term; immediate vesting.
Material Changes
The filing reports the following material changes to corporate governance and personnel:
- Board Appointment: John Schachtel was appointed to the Board of Directors on March 27, 2017.
- Committee Formation: The Board established a Compensation Committee and a Nominating and Corporate Governance Committee.
- Committee Membership: John Schachtel, Joseph Macaluso, and Stanley Wunderlich were appointed to the new committees. Schachtel was named Chairman of the Compensation Committee, and Wunderlich was named Chairman of the Nominating and Corporate Governance Committee. Both Schachtel and Wunderlich were also added to the existing Audit Committee.
Outlook, Risks, and Management Commentary
The filing contains no forward-looking guidance, financial outlook, or discussion of risks and contingencies. Management commentary is limited to the description of Mr. Schachtel's professional background, noting his prior role as Chief Operating Officer of OneMain Financial Holdings, Inc., and his educational credentials (BS from Northwestern University, MBA in Finance from NYU). The filing explicitly states there are no applicable related party transactions.
Investor Verification Checklist
- Verify the total number of outstanding shares to assess the dilution impact of the 5,000-share warrant.
- Confirm the current market price of the stock relative to the $4.01 warrant exercise price.
- Review the full text of the Director Agreement (Exhibit 10.1) and Warrant (Exhibit 4.1) for additional terms not summarized in the 8-K.
- Check subsequent filings for the Company's financial status, as this report contains no financial data.